» Articles » PMID: 32183606

Biological Characteristics Associated with Virulence in Ribotype 002 in Hong Kong

Overview
Date 2020 Mar 19
PMID 32183606
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

infection (CDI) is a common cause of nosocomial diarrhea and can sometimes lead to pseudo-membranous colitis and toxic megacolon. We previously reported that the PCR ribotype 002 was a common ribotype in Hong Kong that was associated with increased mortality. In this study, we assessed bacteriological characteristics and virulence of ribotype 002 compared to other common ribotypes, including ribotypes 012, 014 and 046. We observed significantly higher toxin A ( 0.05) and toxin B (< 0.05) production, sporulation ( 0.001) and germination rates (< 0.0001) in ribotype 002 than other common ribotypes. In a murine model of infection, ribotype 002 caused significantly more weight loss ( < 0.001) and histological damage ( < 0.001) than other common ribotypes. These findings may have contributed to the higher prevalence and mortality observed, and provided mechanistic insights that can help public surveillance and develop novel therapeutics to combat against this infection.

Citing Articles

Commensal-pathogen dynamics structure disease outcomes during Clostridioides difficile colonization.

Fishbein S, DeVeaux A, Khanna S, Ferreiro A, Liao J, Agee W Cell Host Microbe. 2024; 33(1):30-41.e6.

PMID: 39731916 PMC: 11717617. DOI: 10.1016/j.chom.2024.12.002.


Genomic study of European ribotype 002/sequence type 8.

Dost I, Abdel-Glil M, Persson S, Conza K, Oleastro M, Alves F Microb Genom. 2024; 10(7).

PMID: 39051872 PMC: 11316560. DOI: 10.1099/mgen.0.001270.


The Strain and the Clinical Outcome of Infection: A Meta-analysis.

Abou Chakra C, Gagnon A, Lapointe S, Granger M, Levesque S, Valiquette L Open Forum Infect Dis. 2024; 11(3):ofae085.

PMID: 38524230 PMC: 10960606. DOI: 10.1093/ofid/ofae085.


Trends in Incidence and Clinical Outcomes of Clostridioides difficile Infection, Hong Kong.

Guo C, Kwong T, Mak J, Zhang L, Lui G, Wong G Emerg Infect Dis. 2021; 27(12).

PMID: 34812719 PMC: 8632188. DOI: 10.3201/eid2712.203769.

References
1.
Theriot C, Koumpouras C, Carlson P, Bergin I, Aronoff D, Young V . Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains. Gut Microbes. 2011; 2(6):326-34. PMC: 3337121. DOI: 10.4161/gmic.19142. View

2.
Janoir C, Deneve C, Bouttier S, Barbut F, Hoys S, Caleechum L . Adaptive strategies and pathogenesis of Clostridium difficile from in vivo transcriptomics. Infect Immun. 2013; 81(10):3757-69. PMC: 3811758. DOI: 10.1128/IAI.00515-13. View

3.
Merrigan M, Venugopal A, Mallozzi M, Roxas B, Viswanathan V, Johnson S . Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. J Bacteriol. 2010; 192(19):4904-11. PMC: 2944552. DOI: 10.1128/JB.00445-10. View

4.
Furuya-Kanamori L, Riley T, Paterson D, Foster N, Huber C, Hong S . Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities. J Clin Microbiol. 2016; 55(1):216-225. PMC: 5228233. DOI: 10.1128/JCM.01779-16. View

5.
Bacci S, Molbak K, Kjeldsen M, Olsen K . Binary toxin and death after Clostridium difficile infection. Emerg Infect Dis. 2011; 17(6):976-82. PMC: 3358205. DOI: 10.3201/eid/1706.101483. View